InsidersTradesSigma
Seelos Therapeutics, INC.: insider trades · United States · SEC (Form 4)
SEC:seelos-therapeutics-inc-8c9461US·SEC (Form 4)Mcap 0M€Healthcare
Discover the full management transaction log of Seelos Therapeutics, INC., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Seelos Therapeutics, INC. has logged 4 public disclosures. Market capitalisation: €58. The latest transaction was reported on 2 June 2022 — Acquisition. Among the most active insiders: O'Connor Daniel J.. Every trade is accessible without an account.
4
Insider Decl.
0
Thresholds
€80,056
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2023 · cache
0.00 €
Analyst consensus
Income statement
Net income−37.9 M€203.1% margin
Valuation
PER (trailing)0.0x
Beta22.99
Balance sheet & cash
Market cap58 €
Total debt14.2 M€
Free Cash Flow−23.9 M€
Profitability & ownership
ROA-261.1%
% insiders11.2%
% institutions8.8%
Last declaration on 2 June 2022
Declarations4 total
Executives▲Purchase38SEC
€9,18816,000 shares@ €0.5742100.0% of flow
Common Stock
SEC:0001136261-22-000249:0·
Ideal exit: 26 Feb 2023 (T+270)
Executives▲Purchase38SEC
€19,53335,000 shares@ €0.5581100.0% of flow
Common Stock
SEC:0001136261-22-000247:0·
Ideal exit: 20 Feb 2023 (T+270)
Executives◆Grant28SEC
€10,07312,500 shares@ €0.8058100.0% of flow
Common Stock
SEC:0001136261-22-000155:0·
4 of 4 declarations